Seeking Alpha

GERN
  Geron Corporation - NASDAQ

9/15/2014, 5:36 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
GERN vs. ETF Alternatives
Company Description
Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
Sector: Healthcare
Industry: Biotechnology
Country: United States